INS and leukemia: Recent studies demonstrate that prolonged incubation of leukemia cells with imatinib results in the generation of endogenous ceramides [36], which may mediate apoptotic cell death by inhibiting PDGF- and insulin-induced PI 3-kinase activity [37].